Currently set to Index
Currently set to Follow

Science Diabetes mellitus

My Diabetes Coach, a Mobile App-Based Interactive Conversational Agent to Support Type 2 Diabetes Self-Management: Randomized Effectiveness-Implementation Trial
November 4, 2021
0
0
Enying Gong 1, Shaira Baptista 1 2, Anthony Russell 3 4, Paul Scuffham 5, Michaela Riddell 6, Jane Speight 1 2 7, Dominique Bird 4, Emily Williams 8, Mojtaba Lotfaliany 1, Brian Oldenburg 1 Main idea: The MDC program was successfully adopted and used by individuals with type 2 diabetes and significantly improved the users’ […]
Read more
Impact of type 2 diabetes mellitus on mid-term mortality for hypertrophic cardiomyopathy patients who underwent septal myectomy
November 4, 2021
0
0
Shengwei Wang 1, Hao Cui 2, Keshan Ji 3, Changpeng Song 3, Changwei Ren 1, Hongchang Guo 1, Changsheng Zhu 4, Shuiyun Wang 5, Yongqiang Lai 6 Main idea: Hypertrophic cardiomyopathy patients with and without type 2 diabetes mellitus have similar 3-year cardiovascular mortality after septal myectomy. However, type 2 diabetes mellitus is associated with […]
Read more
Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapy
November 4, 2021
0
0
Masato Furuhashi 1, Ichiro Sakuma 2, Takeshi Morimoto 3, Yukimura Higashiura 4, Akiko Sakai 4, Megumi Matsumoto 4, Mio Sakuma 3, Michio Shimabukuro 5, Takashi Nomiyama 6, Osamu Arasaki 7, Koichi Node 8, Shinichiro Ueda 9 Main idea: Anagliptin decreases serum FABP4 concentration independent of change in hemoglobin A1c or LDL-C in patients with type […]
Read more
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
November 4, 2021
0
0
Deepak L Bhatt 1, Michael Szarek 1, P Gabriel Steg 1, Christopher P Cannon 1, Lawrence A Leiter 1, Darren K McGuire 1, Julia B Lewis 1, Matthew C Riddle 1, Adriaan A Voors 1, Marco Metra 1, Lars H Lund 1, Michel Komajda 1, Jeffrey M Testani 1, Christopher S Wilcox 1, Piotr Ponikowski […]
Read more
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes
November 4, 2021
0
0
Christopher P Cannon 1, Richard Pratley 1, Samuel Dagogo-Jack 1, James Mancuso 1, Susan Huyck 1, Urszula Masiukiewicz 1, Bernard Charbonnel 1, Robert Frederich 1, Silvina Gallo 1, Francesco Cosentino 1, Weichung J Shih 1, Ira Gantz 1, Steven G Terra 1, David Z I Cherney 1, Darren K McGuire 1, VERTIS CV Investigators Main […]
Read more
Pioglitazone for the Primary and Secondary Prevention of Cardiovascular and Renal Outcomes in Patients with or at High Risk of Type 2 Diabetes Mellitus: A Meta-Analysis
November 7, 2021
0
0
Yue Zhou 1, Yajing Huang 1, Xiaoyun Ji 1, Xiang Wang 1, Liyan Shen 1, Yangang Wang 1 Main idea: Pioglitazone should be considered in patients with or at high risk of T2DM for the prevention of cardiovascular endpoints, especially in those with a history of established CVD who might benefit the most. Robust reductions […]
Read more
Dipeptidyl peptidase-4 inhibitor treatment could decrease Klebsiella pneumoniae pneumonia in patients with type 2 diabetes
November 7, 2021
0
0
Hsin-Hung Chen 1 2, Ching-Chu Chen 3 4, Chun-Wei Ho 1, Ming-Chia Hsieh 1 5 6, Sheng-Pang Hsu 3, Cheng-Li Lin 7 8, Chia-Hung Kao 9 10 11 12 Main idea: For public health issue with type2 diabetes and infection, DPP4i use decreased Klebsiella pneumoniae pneumonia. Male gender, patients with co-morbidities, patients with higher DSCI […]
Read more
Egg consumption and risk of type 2 diabetes: findings from 3 large US cohort studies of men and women and a systematic review and meta-analysis of prospective cohort studies
November 7, 2021
0
0
Jean-Philippe Drouin-Chartier 1 2 3 4, Amanda L Schwab 1, Siyu Chen 1, Yanping Li 1, Frank M Sacks 1 5, Bernard Rosner 1 5 6, JoAnn E Manson 5 7 8, Walter C Willett 1 5 8, Meir J Stampfer 1 5 8, Frank B Hu 1 5 8, Shilpa N Bhupathiraju 1 5 […]
Read more
Nutritional adequacy of very low- and high-carbohydrate, low saturated fat diets in adults with type 2 diabetes: A secondary analysis of a 2-year randomised controlled trial
November 7, 2021
0
0
Jeannie Tay 1, Campbell H Thompson 2, Natalie D Luscombe-Marsh 3, Manny Noakes 3, Jonathan D Buckley 4, Gary A Wittert 2, Grant D Brinkworth 5 Main idea: In free-living individuals with type 2 diabetes, nutrition biomarkers within normal ranges at baseline did not change significantly after 2 years on a prescribed low-carbohydrate or high-carbohydrate […]
Read more
Non-nutritive sweeteners for diabetes mellitus
November 7, 2021
0
0
Szimonetta Lohner 1, Daniela Kuellenberg de Gaudry 2, Ingrid Toews 3, Tamas Ferenci 4, Joerg J Meerpohl 3 5 Main idea: There is inconclusive evidence of very low certainty regarding the effects of NNS consumption compared with either sugar, placebo, or nutritive low-calorie sweetener consumption on clinically relevant benefit or harm for HbA1c, body weight, […]
Read more